Inhibitor Research Hub

Archives

  • 2026-09
  • 2026-08
  • 2026-07
  • 2026-06
  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • Midecamycin: Mechanism, Benchmarks & Macrolide Research I...

    2026-01-20

    Midecamycin, an acetoxy-substituted macrolide antibiotic, is a potent bacterial protein synthesis inhibitor used exclusively for antibacterial research. Its unique spectrum against Gram-positive and Gram-negative bacteria, coupled with reliable storage and workflow parameters, positions APExBIO’s BA1041 as a benchmark compound for microbiology and antibiotic resistance studies.

406 records 28/28 page Previous First page 上5页 262728